Summary: GLP-1 receptor agonists and other anti-obesity medications (AOMs) are valuable tools in obesity treatment, but they are not standalone solutions. Their effectiveness depends on integration into comprehensive care; achieving this requires policy reforms,...
Summary: A life science company engaged Atlas Clarity to develop a health equity presentation for its staff that provided guidance on who is currently engaged in health equity now, as well as how community health centers can help in aid research to improve health...
Summary: A life science company sought to better understand patient experience with timely diagnosis and treatment of two rare diseases, neuromyelitis optica spectrum disorders (NMOSD) and generalized myasthenia gravis (gMG), particularly among underserved...
Summary: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that causes the body to attack its own organs and tissue. Due to its uncommon nature, it is often hard to diagnose, particularly in disadvantaged populations. While not typically fatal, it...
Summary: Across the United States, community health workers (CHWs) bridge the gap between health and social services and communities, especially those that are underserved. In 2025, Atlas Clarity partnered with Sanofi, NationSwell, and the National Association of...